HPV, careHPV, Asia, Woman, Women's Health, Sexual and Reproductive Health
Gynecological and maternal health

Standing together against cervical cancer

Too many women die from cervical cancer – a disease that is preventable through HPV vaccination and screening. We are proud to be a dedicated, longtime contributor in the fight against cervical cancer, offering a diverse portfolio of screening solutions that addresses a range of clinical needs and laboratory settings.

Despite the notable achievements of global HPV vaccination and screening programs, cervical cancer continues to be a leading killer of women. In fact, it is the fourth most frequent cancer among women worldwide, with 85% of deaths occurring in low- and middle-income countries where screening is not readily available (1). But even countries with robust prevention programs are not free from the threat of cervical cancer, with mothers, daughters, sisters and friends being diagnosed every day.

One of the most effective tools we have in the fight against cervical cancer is HPV screening. While HPV is incredibly common, it usually resolves on its own without intervention and before causing any problems. However, more persistent cases may cause changes to the cervix and potentially progress to cervical cancer if not identified and managed appropriately.

We are your trusted partner in the fight against cervical cancer, offering:

  • Technologies designed to address varying laboratory needs
  • Sample type flexibility to support screening efforts in diverse cultural contexts and resource settings, including the first commercially available self-sampling option for molecular assays
  • Reliable and accurate testing solutions to guide clinical decisions and next steps
  • A portfolio of HPV tests, including the gold standard digene HC2 HPV Test, that are validated by international guidelines

Reaching every woman: our portfolio of HPV screening solutions

Together in the quest to eradicate cervical cancer

QIAsure Methylation Test

Following an HPV-positive result, the QIAsure Methylation Test provides additional molecular insights to aid in evaluating patient management options by accurately identifying women with markers associated with the highest short-term risk for cervical cancer.
Learn more

QIAscreen HPV PCR Test

QIAscreen combines QIAGEN’s leading sample prep excellence from QIAsymphony and Rotor-Gene Q MDx with our expertise in HPV diagnostics. This molecular test provides genotyping of the 15 high-risk HPV types and detects the highly conserved E7 region in the HPV genome.

Learn more

A range of HPV solutions for varying needs

Our portfolio is designed for use in a variety of clinical and laboratory settings, to enable access to cervical cancer screening for women everywhere.
Test Instrument  Tests per run* Throughput estimates (8hr shift)* Technology Targets  Automation Claims Self-sampling Regulation Cat. no.
careHPV Test (2) careHPV System 90 270 Hybrid Capture 2 14 hrHPV targets Manual Screening, Co-testing, ASCUS ✔ WHO prequali­fied, CE-IVD, NMPA 614015
digene HC2 HR HPV Test (3) HC2 System 88 264 Hybrid Capture 2 13 hrHPV targets Manual Screening, Co-testing, ASCUS ✔ CE-IVD, NMPA**, FDA** 5197-1330
digene HC2 HR HPV Test (3) Rapid Capture System (RCS) 88 352 Hybrid Capture 2 13 hrHPV targets Semi-automated Triage  ✔ CE-IVD, NMPA**, FDA** RCS: 6000-3101
QIAsure Methylation Test (4) Manual or QSRGQ 72 72 Real-time methylation-specific PCR (MSP) Biomarkers FAM19A4 & hsa-mir124-2 Semi-automated Screening, Co-testing, ASCUS ✔ CE-IVD 616014
QIAscreen HPV PCR Test (5) Manual or QSRGQ 72 96 DNA extraction and amplification (RT-PCR) 15 hrHPV targets  Semi-automated Screening, Co-testing, ASCUS ✔ CE-IVD 617005

Ready to learn more?
Let us help you find the HPV screening solution that meets your unique needs.
Contact us

References

  1. LaVigna AW, et al. (2017) Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery. Gynecol Oncol Rep. 22, 16–20.
  2. careHPV Test Instructions for Use (handbook). Available at www.qiagen.com.
  3. digene HPV Test Instructions for Use (handbook). Available at www.qiagen.com.
  4. QIAsure Methlyation Test Instruction for Use (handbook). Available at Methylation Test.
  5. QIAscreen PCR HPV Test Instructions for Use (handbook). Available at QIAscreen.